Protecting Minors in Federal Health Plans Act
- Bill Number
- S. 1774
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-15: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- Last Updated
- 2025-05-30T12:05:08Z
AI-Generated Summary
Purpose
The "Protecting Minors in Federal Health Plans Act" (S. 1774) aims to prevent the Federal Employees Health Benefits (FEHB) program—a health insurance plan for U.S. federal employees, retirees, and their families—from covering certain medical treatments related to gender transition for individuals under 18 years old. The goal is to limit access to these treatments through federal health plans for minors, while allowing exceptions for specific medical conditions unrelated to gender dysphoria.
Key Provisions
- Definition of Gender-Affirming Care or Service: This refers to medical interventions intended to treat gender dysphoria (a condition where a person's gender identity differs from their assigned sex at birth). It includes:
- Hormone therapy.
- Puberty blockers (medications that delay puberty).
- Surgical procedures for gender transition.
- Prohibitions: FEHB insurance contracts cannot cover gender-affirming care for anyone under 18, regardless of other laws or regulations.
- Exceptions to the Prohibition:
- Treatments for medically verifiable disorders of sexual development (e.g., ambiguous sex characteristics due to specific chromosomal or hormonal conditions).
- Care for infections, injuries, or disorders caused or worsened by prior gender-affirming interventions.
- Procedures to address life-threatening physical issues (certified by a doctor) that are not for gender transition or to ease gender-related distress.
- Puberty suppression for precocious puberty (early-onset puberty) in those under 18.
- Hormone therapy to stimulate normal puberty in those under 18 with delayed puberty, using hormones matching the individual's biological sex.
- Male circumcision.
- Grandfather Clause for Ongoing Treatment: Minors already receiving covered hormone therapy before the law's effective date can continue it under a doctor-supervised reduction plan that ends within one year.
- Implementation: The rules apply to all FEHB contracts entered into or renewed on or after the date the Act is enacted.
Significant Changes to Existing Law
This bill amends Section 8902 of Title 5 of the U.S. Code, which governs the FEHB program, by adding a new subsection (q). Previously, FEHB plans could cover gender-affirming care for minors if deemed medically necessary, following standard insurance guidelines. The change explicitly bans such coverage for minors, overriding prior approvals or state/federal laws allowing these treatments, while carving out narrow exceptions for non-transition-related care.
Potential Impacts
- On Government Agencies: The Office of Personnel Management (OPM), which oversees FEHB, will need to update contracts with insurers to enforce the ban, potentially increasing administrative costs for compliance and monitoring exceptions.
- On Citizens: Federal employees and their families with minors seeking gender-affirming care will lose FEHB coverage for these treatments, possibly forcing them to pay out-of-pocket, seek other insurance, or forgo care. This could affect an estimated millions of federal workers and dependents, though the exact number of impacted minors is unclear.
- On International Relations: No direct impacts, as the bill focuses on domestic federal health benefits.
Main Stakeholders Affected
- Federal Employees and Families: Primarily those with transgender or gender-dysphoric minors, who may face barriers to care.
- Health Insurers and Providers: FEHB-participating insurance companies must revise plans and deny claims; doctors may need to adjust treatment protocols or certifications for exceptions.
- Minors with Gender Dysphoria: Direct restriction on access to certain treatments through federal plans.
- Advocacy Groups: Organizations supporting or opposing transgender youth healthcare (e.g., medical associations like the American Academy of Pediatrics or conservative policy groups) will likely engage in debates or legal challenges.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: The ban could lead to lawsuits claiming violations of anti-discrimination laws (e.g., under the Affordable Care Act's nondiscrimination provisions) or state laws protecting transgender rights. Courts may scrutinize the exceptions to determine if they adequately balance access to necessary care.
- Constitutional Implications: Potential challenges under the Equal Protection Clause of the 14th Amendment, arguing the law discriminates based on gender identity or sex. It might also raise due process concerns if it interferes with parental rights to medical decisions for children.
- Political Implications: The bill reflects ongoing national debates on youth gender care, potentially influencing broader healthcare policy or state-level laws. As a Senate-introduced measure referred to the Committee on Homeland Security and Governmental Affairs, it highlights partisan divides, with sponsors from Republican senators focused on protecting minors from what they view as irreversible treatments.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Sen. Lummis, Cynthia M. [R-WY], Sen. Ricketts, Pete [R-NE], Sen. Cramer, Kevin [R-ND]
Recent Actions
- 2025-05-15: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- 2025-05-15: Introduced in Senate
Bill Versions
- Protecting Minors in Federal Health Plans Act — issued 2025-05-15 — PDF (5 pages)